News
The outgoing chief executive of Novo Nordisk has revealed plans to ramp-up cost cutting 'efficiencies' across the business, ...
Shares of Novo Nordisk, the Danish pharmaceutical giant behind Ozempic and Wegovy, fell in pre-market trading and on the ...
34m
Asianet Newsable on MSNNovo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance.
Nvidia reiterated that its chips don't-and shouldn't-have back doors or kill switches, days after Beijing summoned the U.S. artificial-intelligence chip giant over national-security concerns. Novo ...
European shares rose Wednesday as earnings proved resilient to the tariff tumult of the second-quarter, even as another cliff-edge for U.S. levies loomed . The STOXX Europe 600 was on course for its ...
Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results